Ages above 65 years, PLT count, TNF‐α rs1800750 variant genotype, blast percentage, LDH level, and cytogenetic high‐risk may be used as independent risk factors to assess AML mortality. This evidence concerns the gene TNF and acute myeloid leukemia.